Position in VCEL
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$368,510
+$167,760 QoQ
Shares Held
8,283
+75.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#42
of 96 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JUNCTURE WEALTH STRATEGIES, LLC holds $4,939,567 across 9 Biotechnology names. VCEL ranks #7 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
11,865 | $928,673 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
10,577 | $862,765 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
34,232 | $580,917 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
18,408 | $578,563 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
4,815 | $563,692 | |
| 6 | INCY |
Incyte Corp
|
4,956 | $561,812 | |
| 7 | VCEL |
Vericel Corp
This page
|
8,283 | $368,510 | |
| 8 | TBPH |
Theravance Biopharma, Inc.
|
17,234 | $292,978 |
All Filings in VCEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $368,510 | 8,283 | Shares | Sole | 2026-07-09 | |
| 2025-06-30 | $200,750 | 4,718 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $411,664 | 9,226 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $568,483 | 10,353 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $491,916 | 11,643 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $360,616 | 7,860 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $208,964 | 4,017 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||